GREEN DAVID 4

4 · Biostage, Inc. · Filed Nov 30, 2021

Form 4

Period: 2021-11-26

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2021-11-26$3.45/sh+72,464$250,001→ 95,516 total
Purchase
Warrant (right to buy)
2021-11-26+36,232→ 36,232 total
Exercise: $3.45From: 2021-11-26Exp: 2026-11-26→ Common Stock, par value $0.01 per share (36,232 underlying)
Award
Stock Option (right to buy)
2021-11-26+374,094→ 374,094 total
Exercise: $2.40Exp: 2031-11-26→ Common Stock, par value $0.01 per share (374,094 underlying)

Holdings

Footnotes (2)

[F1]On November 26, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 72,464 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) a warrant to purchase up to 36,232 shares of common stock with an exercise price of $2.00 per share (the "Warrant"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrant acquired by it pursuant to the Purchase Agreement was $250,000.
[F2]Subject to continued employment or service through the applicable vesting dates, (i) 106,884 shares will vest monthly in twelve equal monthly installments on each monthly anniversary of November 26, 2021, and (ii) up to 267,210 shall vest in three increments, two for 80,163 shares each and the third for 106,884 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.

Documents

1 file